Cartesian TherapeuticsRNAC

13F holders, Q2 2024 (June 30)
61holders +57
57new positions
1sold out
1famous investor
$26.98avg. 13F price*

At the end of Q2 2024, 61 institutions reported holding Cartesian Therapeutics Inc. (RNAC) in their 13F filings, up 57 from Q1 2024. 57 opened new positions and 1 sold out. The largest holders were FMR LLC ($13.8M), BlackRock Inc. ($11.0M) and JPMorgan Chase & Co. ($8.3M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Cartesian Therapeutics Inc.
CUSIP
816212302
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080100 Q1 2024: 4Q1 2024Q2 2024: 61Q2 2024Q3 2024: 64Q3 2024Q4 2024: 68Q4 2024Q1 2025: 72Q1 2025Q2 2025: 66Q2 2025Q3 2025: 68Q3 2025Q4 2025: 67Q4 2025Q1 2026: 83Q1 2026Q2 2026: 94Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions57$88.1M
Exits1$10

All 13F filers, Q1 2024 → Q2 2024: 3,266,193 shares bought and 1,795 shares sold, net +3,264,398 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 61 holders

FMR LLC 0.00% New 510,776 $13.8M
BlackRock Inc. 0.00% New 407,596 $11.0M
JPMorgan Chase & Co. 0.00% New 306,330 $8.3M
Artal Group S.A. 0.21% New 304,554 $8.2M
MPM Bioimpact LLC 1.09% New 259,696 $7.0M
Ikarian Capital, LLC 2.04% New 242,370 $6.5M
Vanguard Group Inc. 0.00% New 236,657 $6.4M
State Street Corp. 0.00% New 153,665 $4.2M
Geode Capital Management, LLC 0.00% New 132,963 $3.6M
Erste Asset Management GmbH 0.04% New 122,233 $3.3M
Yale University 77.59% New 100,000 $2.7M
Logos Global Management LP 0.28% New 90,000 $2.4M
Boothbay Fund Management, LLC 0.06% New 68,540 $1.9M
Nuveen Asset Management, LLC 0.00% New 34,750 $939K
Lake Street Advisors Group, LLC 0.04% New 31,644 $855K
Northern Trust Corp. 0.00% New 30,924 $835K
Marshall Wace, LLP 0.00% New 30,038 $811K
Sphera Funds Management LTD. 0.11% New 25,070 $677K
Delphi Financial Group, Inc. 0.34% New 22,028 $595K
Bank of New York Mellon Corp 0.00% New 19,916 $538K
Charles Schwab Investment Management Inc. 0.00% New 19,048 $514K
Renaissance Technologies 0.00% New 17,052 $461K
Cubist Systematic Strategies, LLC 0.01% New 13,010 $351K
Bridgeway Capital Management, LLC 0.01% New 10,193 $275K
Twin Focus Capital Partners, LLC 0.04% New 10,000 $270K
Rhumbline Advisers 0.00% New 8,487 $229K
Freestone Capital Holdings, LLC 0.01% New 8,000 $216K
Morgan Stanley 0.00% New 7,247 $196K
Bank of America Corp. 0.00% New 5,256 $142K
New York State Common Retirement Fund 0.00% New 5,102 $138K
Corebridge Financial, Inc. 0.00% — 3,888 $105K
Barclays PLC 0.00% New 3,762 $102K
Deutsche Bank AG 0.00% New 3,638 $98K
Royal Bank of Canada 0.00% New 2,813 $76K
MetLife Investment Management, LLC 0.00% New 2,428 $66K
Wells Fargo & Company 0.00% New 2,367 $64K
UBS Group AG 0.00% New 2,237 $60K
Point72 Asia (Singapore) Pte. Ltd. 0.01% New 1,824 $49K
Hall Laurie J Trustee 0.02% New 1,759 $48K
Tower Research Capital LLC (TRC) 0.00% New 1,765 $48K
Point72 (DIFC) Ltd 0.00% New 1,725 $47K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% — 1,627 $44K
Citigroup Inc. 0.00% New 1,572 $42K
Legal & General Group Plc 0.00% New 801 $22K
BNP Paribas Financial Markets 0.00% New 742 $20K
Ameritas Investment Partners, Inc. 0.00% New 708 $19K
California State Teachers Retirement System 0.00% New 524 $14K
Osaic Holdings, Inc. 0.00% New 234 $6K
Russell Investments Group, Ltd. 0.00% New 152 $4K
Amalgamated Bank 0.00% New 130 $4K
Activest Wealth Management 0.00% New 66 $2K
WR Wealth Planners, LLC 0.00% Reduce -96.8% 39 $1K
National Bank of Canada 0.00% New 40 $970
Mirae Asset Global Investments Co., Ltd. 0.00% New 3,715 $669
Farther Finance Advisors, LLC 0.00% Reduce -96.7% 18 $436
Nisa Investment Advisors, LLC 0.00% New 14 $378
Arax Advisory Partners 0.00% New 12 $325
Parallel Advisors, LLC 0.00% Reduce -97.0% 3 $81
Hazlett, Burt & Watson, Inc. 0.00% New 12 $0
Capital Advisors, Ltd. LLC 0.00% New 5 $0
FNY Investment Advisers, LLC 0.00% New 3 $0

"% of holder's portfolio" is RNAC's weight in each manager's 13F, not the share of Cartesian Therapeutics Inc. the manager owns.